美国慢性阻塞性肺病(COPD)的疾病负担和与健康相关的生活质量(HRQoL)--来自 2016-2019 年医疗支出面板调查(MEPS)的证据

IF 2.8 3区 医学 Q1 Medicine
Melissa H Roberts, David M Mannino, Douglas W Mapel, Orsolya Lunacsek, Shahla Amin, Eileen Farrelly, Norbert Feigler, Michael F Pollack
{"title":"美国慢性阻塞性肺病(COPD)的疾病负担和与健康相关的生活质量(HRQoL)--来自 2016-2019 年医疗支出面板调查(MEPS)的证据","authors":"Melissa H Roberts, David M Mannino, Douglas W Mapel, Orsolya Lunacsek, Shahla Amin, Eileen Farrelly, Norbert Feigler, Michael F Pollack","doi":"10.2147/copd.s446696","DOIUrl":null,"url":null,"abstract":"<strong>Purpose:</strong> Chronic obstructive pulmonary disease (COPD) is a progressive disease associated with reduced life expectancy, increased morbidity, mortality, and cost. This study characterized the US COPD burden, including socioeconomic and health-related quality of life (HRQoL) outcomes.<br/><strong>Study Design and Methods:</strong> In this retrospective, cross-sectional study using nationally representative estimates from Medical Expenditures Survey (MEPS) data (2016– 2019), adults (≥ 18 years) living with and without COPD were identified. Adults living without COPD (control cohort) and with COPD were matched 5:1 on age, sex, geographic region, and entry year. Demographics, clinical characteristics, socioeconomic, and generic HRQoL measures were examined to include a race-stratified analysis of people living with COPD.<br/><strong>Results:</strong> A total of 4,135 people living with COPD were identified; the matched dataset represented a weighted non-institutionalized population of 11.3 million with and 54.2 million people without COPD. Among people living with COPD, 66.3% had ≥ 1 COPD-related condition; 62.7% had ≥ 1 cardiovascular condition, compared to 33.5% and 50.5% without COPD. More people living with COPD were unemployed (56.2% vs 45.3%), unable to work due to illness/disability (30.1% vs 12.1%), had problems paying bills (16.1% vs 8.8%), reported poorer perceived health (fair/poor: 36.2% vs 14.4%), missed more working days due to illness/injury per year (median, 2.5 days vs 0.0 days), and had limitations in physical functioning (40.1% vs 19.4%) (all <em>P</em>&lt; 0.0001). In race-stratified analyses for people living with COPD, people self-reporting as Black had higher prevalence of cardiovascular-risk conditions, poorer socioeconomic and HRQoL outcomes, and higher healthcare expenses than White or Other races.<br/><strong>Conclusion:</strong> Adults living with COPD had higher clinical disease burden, lower socioeconomic status, and reduced HRQoL than those without, with greater disparities among Black people living with COPD compared to White and other races. Understanding the characteristics of patients helps address care disparities and access challenges.<br/><br/><strong>Keywords:</strong> COPD, burden of illness, healthcare cost, race/ethnicity<br/>","PeriodicalId":13792,"journal":{"name":"International Journal of Chronic Obstructive Pulmonary Disease","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2024-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Disease Burden and Health-Related Quality of Life (HRQoL) of Chronic Obstructive Pulmonary Disease (COPD) in the US – Evidence from the Medical Expenditure Panel Survey (MEPS) from 2016-2019\",\"authors\":\"Melissa H Roberts, David M Mannino, Douglas W Mapel, Orsolya Lunacsek, Shahla Amin, Eileen Farrelly, Norbert Feigler, Michael F Pollack\",\"doi\":\"10.2147/copd.s446696\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<strong>Purpose:</strong> Chronic obstructive pulmonary disease (COPD) is a progressive disease associated with reduced life expectancy, increased morbidity, mortality, and cost. This study characterized the US COPD burden, including socioeconomic and health-related quality of life (HRQoL) outcomes.<br/><strong>Study Design and Methods:</strong> In this retrospective, cross-sectional study using nationally representative estimates from Medical Expenditures Survey (MEPS) data (2016– 2019), adults (≥ 18 years) living with and without COPD were identified. Adults living without COPD (control cohort) and with COPD were matched 5:1 on age, sex, geographic region, and entry year. Demographics, clinical characteristics, socioeconomic, and generic HRQoL measures were examined to include a race-stratified analysis of people living with COPD.<br/><strong>Results:</strong> A total of 4,135 people living with COPD were identified; the matched dataset represented a weighted non-institutionalized population of 11.3 million with and 54.2 million people without COPD. Among people living with COPD, 66.3% had ≥ 1 COPD-related condition; 62.7% had ≥ 1 cardiovascular condition, compared to 33.5% and 50.5% without COPD. More people living with COPD were unemployed (56.2% vs 45.3%), unable to work due to illness/disability (30.1% vs 12.1%), had problems paying bills (16.1% vs 8.8%), reported poorer perceived health (fair/poor: 36.2% vs 14.4%), missed more working days due to illness/injury per year (median, 2.5 days vs 0.0 days), and had limitations in physical functioning (40.1% vs 19.4%) (all <em>P</em>&lt; 0.0001). In race-stratified analyses for people living with COPD, people self-reporting as Black had higher prevalence of cardiovascular-risk conditions, poorer socioeconomic and HRQoL outcomes, and higher healthcare expenses than White or Other races.<br/><strong>Conclusion:</strong> Adults living with COPD had higher clinical disease burden, lower socioeconomic status, and reduced HRQoL than those without, with greater disparities among Black people living with COPD compared to White and other races. Understanding the characteristics of patients helps address care disparities and access challenges.<br/><br/><strong>Keywords:</strong> COPD, burden of illness, healthcare cost, race/ethnicity<br/>\",\"PeriodicalId\":13792,\"journal\":{\"name\":\"International Journal of Chronic Obstructive Pulmonary Disease\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2024-05-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Chronic Obstructive Pulmonary Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/copd.s446696\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Chronic Obstructive Pulmonary Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/copd.s446696","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

目的:慢性阻塞性肺病(COPD)是一种进展性疾病,与预期寿命缩短、发病率、死亡率和成本增加有关。本研究描述了美国慢性阻塞性肺病负担的特点,包括社会经济和与健康相关的生活质量(HRQoL)结果:在这项回顾性横断面研究中,研究人员利用具有全国代表性的医疗支出调查(MEPS)数据(2016-2019 年)估算,确定了患有和未患有慢性阻塞性肺病的成年人(≥ 18 岁)。未患有慢性阻塞性肺病的成年人(对照组)与患有慢性阻塞性肺病的成年人在年龄、性别、地理区域和入选年份上以 5:1 的比例进行匹配。研究人员对慢性阻塞性肺病患者的人口统计学、临床特征、社会经济和一般 HRQoL 指标进行了研究,并对其进行了种族分层分析:结果:共确定了 4135 名慢性阻塞性肺病患者;匹配数据集代表了加权非住院人口中的 1130 万慢性阻塞性肺病患者和 5420 万非慢性阻塞性肺病患者。在慢性阻塞性肺病患者中,66.3%的人患有≥1种与慢性阻塞性肺病相关的疾病;62.7%的人患有≥1种心血管疾病,而没有慢性阻塞性肺病的人分别为33.5%和50.5%。更多的慢性阻塞性肺病患者失业(56.2% 对 45.3%)、因疾病/残疾无法工作(30.1% 对 12.1%)、支付账单有困难(16.1% 对 8.8%)、健康状况较差(一般/较差:36.2% 对 14.4%)、每年因疾病/受伤缺勤的工作日较多(中位数为 2.5 天对 0.0 天)、身体功能受限(40.1% 对 19.4%)(所有 P< 0.0001)。在对慢性阻塞性肺病患者进行的种族分层分析中,与白人或其他种族相比,自我报告为黑人的患者的心血管风险患病率更高,社会经济和 HRQoL 结果更差,医疗费用更高:与没有慢性阻塞性肺病的人相比,患有慢性阻塞性肺病的成年人的临床疾病负担更重、社会经济地位更低且心身健康质量更差,与白人和其他种族的人相比,患有慢性阻塞性肺病的黑人之间的差异更大。了解患者的特征有助于解决护理差异和就医难题:慢性阻塞性肺病 疾病负担 医疗成本 种族/族裔
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Disease Burden and Health-Related Quality of Life (HRQoL) of Chronic Obstructive Pulmonary Disease (COPD) in the US – Evidence from the Medical Expenditure Panel Survey (MEPS) from 2016-2019
Purpose: Chronic obstructive pulmonary disease (COPD) is a progressive disease associated with reduced life expectancy, increased morbidity, mortality, and cost. This study characterized the US COPD burden, including socioeconomic and health-related quality of life (HRQoL) outcomes.
Study Design and Methods: In this retrospective, cross-sectional study using nationally representative estimates from Medical Expenditures Survey (MEPS) data (2016– 2019), adults (≥ 18 years) living with and without COPD were identified. Adults living without COPD (control cohort) and with COPD were matched 5:1 on age, sex, geographic region, and entry year. Demographics, clinical characteristics, socioeconomic, and generic HRQoL measures were examined to include a race-stratified analysis of people living with COPD.
Results: A total of 4,135 people living with COPD were identified; the matched dataset represented a weighted non-institutionalized population of 11.3 million with and 54.2 million people without COPD. Among people living with COPD, 66.3% had ≥ 1 COPD-related condition; 62.7% had ≥ 1 cardiovascular condition, compared to 33.5% and 50.5% without COPD. More people living with COPD were unemployed (56.2% vs 45.3%), unable to work due to illness/disability (30.1% vs 12.1%), had problems paying bills (16.1% vs 8.8%), reported poorer perceived health (fair/poor: 36.2% vs 14.4%), missed more working days due to illness/injury per year (median, 2.5 days vs 0.0 days), and had limitations in physical functioning (40.1% vs 19.4%) (all P< 0.0001). In race-stratified analyses for people living with COPD, people self-reporting as Black had higher prevalence of cardiovascular-risk conditions, poorer socioeconomic and HRQoL outcomes, and higher healthcare expenses than White or Other races.
Conclusion: Adults living with COPD had higher clinical disease burden, lower socioeconomic status, and reduced HRQoL than those without, with greater disparities among Black people living with COPD compared to White and other races. Understanding the characteristics of patients helps address care disparities and access challenges.

Keywords: COPD, burden of illness, healthcare cost, race/ethnicity
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.10
自引率
10.70%
发文量
372
审稿时长
16 weeks
期刊介绍: An international, peer-reviewed journal of therapeutics and pharmacology focusing on concise rapid reporting of clinical studies and reviews in COPD. Special focus will be given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self management protocols. This journal is directed at specialists and healthcare professionals
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信